The RNase H activity of reverse transcriptase carries out three types of cleavage termed internal, RNA 5' end-directed, and DNA 3' end-directed.
nucleotides for M-MuLV. Substrates with an RNA 5' end recessed by 1 (HIV-1) or 2-3 (MMuLV) bases on a longer DNA can accommodate both types of end-directed cleavage, but further recession of the RNA 5' end excludes DNA 3' end-directed cleavages. For HIV-1 RNase H, the inclusion of the cognate dNTP enhances DNA 3' end-directed cleavages at the 17 th and 18 th nucleotides. These data demonstrate that all three modes of retroviral RNase H cleavage share sequence determinants that may be useful in designing assays to identify inhibitors of retroviral RNases H.
During reverse transcription, a retrovirus produces a double-stranded terminally redundant DNA from a single-stranded plus-sense RNA genome (reviewed in (1,2) ). Minus-strand DNA synthesis is initiated with a host cell-derived tRNA, while plus-strand DNA synthesis is initiated with a primer generated from a polypurine tract (PPT) in the viral RNA genome. This replication process is carried out by a viralencoded protein termed reverse transcriptase that contains two enzymatic activities. The amino terminal two-thirds of reverse transcriptase has a DNA polymerase activity that utilizes RNA or DNA as a template while the C-terminal one-third has an RNase H activity that degrades the RNA strand of RNA/DNA hybrids. Both activities are required for viral replication (3) (4) (5) (6) .
RNase H has several roles in reverse transcription (reviewed in (7, 8) ). First, RNase H extensively degrades the RNA genome, which assists plus-strand synthesis, strand transfers and recombination. Second, RNase H specifically cleaves the viral genome to generate the PPT primer required for plus-strand synthesis. Third, RNase H removes the tRNA and PPT primers after minus-strand and plus-strand DNAs are initiated. Because of these multiple functions, RNase H is considered a potential target of anti-virals in the treatment of patients infected with human immunodeficiency virus, type 1 (HIV-1) (reviewed in (9) ).
Both the heterodimeric reverse transcriptase of HIV-1 and the monomeric reverse transcriptase of Moloney murine leukemia virus (M-MuLV) represent excellent model systems to study the enzymatic mechanism and properties of retroviral RNase H. Crystallography studies have shown that the DNA polymerase domains of the human and murine enzymes have similar nucleic acid binding clefts for the double-stranded primertemplate, and that their RNase H domains share very comparable tertiary folds (10) (11) (12) (13) (14) .
In addition, co-crystal structures have shown that the 2 3' end of a DNA primer makes multiple contacts with the polymerase domain of HIV-1 reverse transcriptase, and that the active site of the RNase H domain is 17 or 18 nucleotides away, depending upon whether the substrate is a DNA/DNA or an RNA/DNA duplex (12, 13, 15) . However, the human and murine enzymes each display distinctive structural features that might uniquely influence substrate interactions and consequently RNase H activity, such as a longer connection domain in the M-MuLV reverse transcriptase or the absence of the C-helix in the HIV-1 RNase H domain.
Depending upon how reverse transcriptase associates with an RNA/DNA hybrid, the RNase H activity carries out three distinct types of cleavage: internal, RNA 5' end-directed, and DNA 3' end-directed (reviewed in (8, 16) ). Internal cleavage can occur when reverse transcriptase binds a hybrid without associating with the end of a recessed strand (17) (18) (19) (20) (21) . Instead of occurring at random sites, our recent studies have shown that sequence features both upstream and downstream of a cleavage site represent important determinants for the positioning of internal cleavages by the RNases H of HIV-1 and M-MuLV (22) . However, the polymerase domain of reverse transcriptase preferentially associates with a recessed strand end in an RNA/DNA hybrid, and such interactions direct more extensive RNase H cleavages that are termed RNA 5' enddirected or DNA 3' end-directed, depending upon whether the recessed end is RNA or DNA, respectively (23) (24) (25) (26) .
Many studies have examined the RNA 5' end-directed or the DNA 3' end-directed mode of cleavage separately.
RNA 5' end-directed cleavages have previously been observed to occur as close as 7 nucleotides and as far as 21 nucleotides from the recessed RNA 5' end (for example, see (23, (26) (27) (28) (29) (30) (31) ). Recently we showed that, like internal cleavages, a site recognized by RNA 5' end-directed cleavage is characterized by preferred nucleotides flanking the cleavage site and, in addition, cleavage preferentially occurs within a "cleavage window" that ranges between 13 to 19 nucleotides from the RNA 5' end (31) . A possible explanation for the existence of this cleavage window is that the enzyme associates only loosely with the recessed RNA 5' end, and then prior to cleavage slides in either direction to a site corresponding to the nucleotide sequence preference of the retroviral RNase H.
Unlike RNA 5' end-directed cleavages where the structural basis for the association of the enzyme with the recessed end is unknown, the polymerase domain of reverse transcriptase is expected to strongly engage a recessed DNA 3' end for potential use as a primer in DNA synthesis (12, 13, 15) . This consideration suggested the possibility that DNA 3' end-directed cleavages by RNase H might occur at a fixed distance from the recessed end and without any preference for nucleotide sequence. The alternative hypothesis is that DNA 3' end-directed cleavages occur at specific sites within a window similar to what we have described previously for RNA 5' end-directed cleavage. In other reports where DNA 3' enddirected cleavage has been studied, cleavage sites have been reported in the range from 15 to 20 nucleotides from the recessed DNA 3' terminus (for example, see (27, (32) (33) (34) ), but no attempt was made to systematically determine whether the cleavage sites must fall within a cleavage window or simply reflected differences in the structure of the RNA/DNA hybrid substrate. To distinguish between these possibilities and to further explore the basis for the interaction of reverse transcriptase with substrates containing different types of recessed ends, in this report we directly compare the cleavage sites preferred by the DNA 3' enddirected versus RNA 5' end-directed types of RNase H cleavage on matched hybrid substrates with the same nucleotide sequence. The results indicate that, similar to RNA 5' end-directed cleavage, DNA 3' end-directed cleavage occurs at specific sites in the substrate, but the allowable window for cleavage is distinct from that described for RNA 5' end-directed cleavage.
Interestingly, several non-nucleotide reverse transcriptase inhibitors (NNRTIs) that inhibit the polymerase activity of HIV-1 reverse transcriptase have been reported to increase DNA 3' end-directed cleavages while partially suppressing RNA 5' end-directed cleavages (35) . These results indicate that anti-viral drugs can differentially influence what type of RNase H cleavage occurs. Consequently, identifying and characterizing all of the determinants that direct the internal, DNA 3' end-directed, and RNA 5' end-directed types of RNase H cleavage are essential both for a general understanding of retroviral replication and for developing assays to identify new inhibitors of HIV-1 reverse transcriptase.
Experimental Procedures
Reagents and Enzymes-Recombinant M-MuLV reverse transcriptase and ddNTPs were purchased from Amersham Pharmacia Biotech. Recombinant HIV-1 reverse transcriptase was obtained from Worthington Biochemicals, and dNTPs from Invitrogen. T7 DNA polymerase and calf intestinal alkaline phosphatase were obtained from USB/Affymetrix, while all other DNA modifying enzymes and restriction enzymes were purchased from New England Biolabs. DNA oligonucleotides were obtained from Eurofins MWG Operon and Bioneer, Inc.
In vitro transcripts were prepared using the MEGAshortscript TM Kit from Ambion. RNA and DNA strands used in hybrid substratesPreparation of RNAs Md1, Md4, Md7, Md9, and R46 was described previously (22, 31) . The 5' end of 46-mer R46 begins with 8 nucleotides of nonviral sequence derived from the template used for in vitro transcription (numbered T1 to T8 from 5' to 3'; see Fig. 1 ) followed by the first 38 nucleotides of sequence (numbered +1 to +38) downstream of the cleavage site in the M-MuLV genome that creates the PPT primer (defined as the +1/-1 site). To prepare R-63/-23, a 49-mer DNA oligonucleotide (5'-CGCCTATAGAGTACGAGC CATAGATAAAATAAAAGATTTTATTGAGA CG-3') was annealed to a 57-mer DNA oligonucleotide (5'-AATTCGTCTCAATAAAAT CTTTTATTTTATCTATGGCTCGTACTCTATA GGCGAGCT-3') to form a duplex that was placed into EcoRI-and SacI-linearized pGEM9Zf(-) (Promega), and the resulting plasmid was linearized with BsmBI and transcribed in vitro as previously described (20) . The resulting 49-mer RNA R-63/-23 begins with the same 8 nucleotides as R46 (T1 to T8 from 5' to 3'; see Fig.  1 ) followed by 41 nucleotides of sequence (numbered as -63 to -23 from 5' to 3') upstream of the M-MuLV PPT primer cleavage site.
The sequences of DNAs Cd1, Cd4, Cd7, and Cd9 are complementary to RNAs Md1, Md4, Md7, and Md9, respectively, and are shown in Figure 1 . DNA D46 is identical in length and complementary to RNA R46.
RNAs and oligonucleotides were gel-purified in denaturing polyacrylamide gels as previously described (20, 22) . Preparation of hybrid substrates-RNAs were labeled at the 5' end or the 3' end (described previously in (20, 22) ) as specified in the figure legends, and annealed to the indicated DNAs at an RNA:DNA molar ratio of 1:2 in 10 mM Tris-HCl, pH 8.0, and 200 mM KCl at 90 ºC for 3 min followed by cooling to room temperature. For the hybrid substrates used to analyze the transition between RNA 5' end-directed cleavage and DNA 3' end-directed cleavage, the substrate with a recessed DNA 3' end was generated by annealing Cd9 to R46. The blunt end substrate contained RNA Md9 annealed to a DNA strand with the sequence 5'-GCTAGCTTGCCAA ACCTACAGGTGGGGT-3' such that the DNA 3' end was co-terminal with the 5' end of Md9 and the DNA 5' end was recessed by 1 base from the 3' end of Md9. Substrates in which the RNA 5' end of Md9 was progressively recessed were generated by annealing Md9 to DNAs containing the preceding underlined sequence and additional bases at the DNA 3' end as follows: recessed 1 base (5'-…C-3'); recessed 2 bases (5'-…CT-3'), recessed 3 bases (5'-…CTT-3'), recessed 8 bases (5'-…CTTTCATT-3'), recessed 11 bases (5'-…CTTTCATTGAG-3'), recessed 38 bases (5'-…CTTTCATTGAGCTCCCCCCCCCTTTTTCT GGAGACTAA-3').
The size of the cleavage window for DNA 3' end-directed cleavages was determined with hybrids containing R46 or R-63/-23 ( Fig. 1) . For hybrid substrates containing R46, the complementary DNAs had 5' ends beginning at position +36 and 3' ends located from position T6 to position +13 in R46. For hybrid substrates containing R-63/-23, the complementary 30-mer DNAs had 5' ends that were recessed by at least 2 bases from the 3' end of R-63/-23 and 3' ends that were positioned at 13 successive nucleotides, beginning at position -62 and ending at position -50 in R-63/-23.
To analyze the effects of dNTPs on RNase H cleavage, hybrid substrates were generated by annealing 31-mer DNA strands with 3' ends located 15 to 20 nucleotides upstream of the site -41/-40 located in R-63/-23 (Fig. 1B) . To prepare these DNA strands, the complementary 30-mer DNAs with 3' ends at every position from -59 to -54 in R-63/-23 (described above) were annealed to a DNA version of R-63/-23 and then extended by 1 nucleotide with the appropriate ddNTP and T7 DNA polymerase. Reactions were carried out in 40 mM Tris-HCl (pH 7.5), 20 mM MgCl 2 , 50 mM NaCl, 0.1 mM DTT, and 300 µM ddNTP for 60 min at 37 ºC followed by gelpurification of the dideoxy-extended DNA. The resulting primers were named Primers 15, 16, 17, 18, 19, and 20, referring In the experiments comparing the effects of cognate versus non-cognate dNTPs on RNase H cleavage, reactions additionally contained 50 µM, 200 µM, or 1000 µM of a non-cognate dNTP or the cognate dNTP, as determined by the template strand sequence. For Primers 15, 16, 17, 18, 19 , and 20, the cognate dNTPs used were dCTP, dTTP, dATP, dTTP, dATP, or dGTP, respectively, and the non-cognate dNTPs used were dGTP, dATP, dTTP, dATP, dTTP, or dCTP, respectively. Products were analyzed in denaturing 15% polyacrylamide gels and visualized as described above.
RESULTS
Comparison of DNA 3' end-and RNA 5' end-directed cleavages using matched hybrid substrates. Earlier studies with HIV-1 and MMuLV reverse transcriptases have shown that the sequence containing the PPT region of M-MuLV has several RNase H cleavage sites (previously named A -I) that are located downstream of the specific cleavage site generating the 3' end of the PPT primer (defined as occurring between positions -1 and +1 in the M-MuLV sequence) (18, 20) . Depending upon substrate structure, the sites that are recognized by each enzyme can be cleaved in either the RNA 5' end-directed or internal modes of RNase H cleavage. Recognition of a particular site sometimes differs between the two enzymes, and is explained by the unique nucleotide preferences of the HIV-1 or M-MuLV reverse transcriptase for the sequence surrounding a given RNase H cleavage site (22) . The sequence downstream of the M-MuLV PPT containing these sites is found in RNA R46 RNA and the positions of the relevant sites E -I are indicated in Fig. 1A .
Using the HIV-1 and M-MuLV reverse transcriptases, we examined how these sites were recognized by the DNA 3' end-directed type of RNase H cleavage.
Hybrids that contained recessed DNA 3' ends at varied locations relative to sites E -I were generated by annealing DNAs Cd1, Cd4, Cd7, or Cd9 to RNA R46 (Fig. 1A) . To directly compare the relative positions of DNA 3' end-directed cleavages to RNA 5' end-directed cleavages, matching substrates containing recessed RNA 5' ends with identical hybrid sequences were generated as well. As an example in Fig. 1A , the matched hybrid substrates with end positions designated as Pair 1 consist of one substrate containing Cd1 annealed to R46 (recessed DNA 3' end), and one substrate containing Md1 annealed to the DNA equivalent of R46 (recessed RNA 5' end; not shown). A total of 4 pairs of matched hybrid substrates containing the sequences for Cd1, Cd4, Cd7, Cd9 and their RNA counterparts were generated ( Fig. 2A) . Importantly, these hybrids all contained cleavage sites E -I but these sites were found at different distances from the recessed ends in each hybrid pair.
The pairs of matched hybrids containing 5' end-labeled RNAs were treated with HIV-1 reverse transcriptase in time course assays and the resulting products generated by RNase H cleavage at the same sites in each pair are indicated by dashed lines (Fig. 2B-2E ). To consider the cleavage sites initially recognized by RNA 5' endor DNA 3' end-directed cleavage, only the major products generated in the 0.25 and 1 min time points were evaluated and are indicated by filled circles at the left of each panel. In substrate Pair 1, sites E, F, and G are found 13, 16, and 19 nucleotides, respectively, from the recessed ends in both hybrids (Fig. 2B, lanes 1-10) . In the substrate with a recessed RNA 5' end, HIV-1 RNase H primarily cleaved at sites from E to F, and at site G (Fig. 2B, lanes 2-3) . In contrast, HIV-1 RNase H cleaved the equivalent substrate with a recessed DNA 3' end primarily at sites F and G but not at sites closer to the 5' end, including site E (Fig. 2B, lanes 7-8) . In Pair 4, sites F, G, and H are found 13, 16 and 19 nucleotides from the recessed ends, respectively (Fig. 2C, lanes 1-10) . When the substrate has a recessed RNA 5' end, site F was cleaved but when the substrate has a recessed DNA 3' end, sites G and H were cleaved efficiently (Fig. 2C , compare lanes 2, 3 and 7, 8) . In Pair 7, sites F, G, and H are 10, 13, and 16 nucleotides, respectively, from the recessed hybrid ends, and RNA 5' end-directed cleavages occurred at each of these sites, but DNA 3' end-directed cleavage strongly favored site H (Fig. 2D , lanes 1-10). In a last example, the substrates of Pair 9 have sites H and I located 14 and 19 nucleotides from the recessed end (Fig. 2E , lanes 1-10), and HIV-1 RNase H cleaved at site H when the recessed end was RNA and at site I when the recessed end was DNA (Fig. 2E , compare lanes 2, 3 and 7,8) .
These data reveal that HIV-1 RNase H did not cleave at the same distance from a recessed DNA 3' end in the hybrid substrates as would be predicted if rigid positioning of the 3' end in the polymerase active site strictly determined the cleavage specificity. Instead, HIV-1 RNase H recognized the same sites by DNA 3' end-directed and RNA 5' end-directed cleavages, but site selection was different in each pair of substrates. For example, the most extensive cleavage at site H occurred by DNA 3' end-directed cleavage in Pair 7, and by RNA 5' end-directed cleavage in Pair 9 ( These matched pairs of hybrid substrates were also used in RNase H cleavage assays with M-MuLV reverse transcriptase (Fig. 3) . In Pair 1, substrate with a recessed RNA 5' end was primarily cleaved at sites E and F while substrate with a recessed DNA 3' end was primarily cleaved at site G (Fig. 3A, lanes 1-10) . With Pair 4, substrate with a recessed RNA 5' end was mostly cleaved at site F and the site just 3' of F, whereas a substrate with a recessed DNA 3' end was primarily cleaved at site H (Fig. 2B, lanes 1-10) . In Pair 7, a more subtle difference in cleavage was observed, with RNA 5' end-directed cleavages occurring at sites H and H', and DNA 3' enddirected cleavages occurring at site H' and beyond (Fig. 3C, lanes 1-10) . Finally, using Pair 9 substrates, cleavage primarily occurred at site H' with a recessed RNA 5' end and at site I with a recessed DNA 3' end ( Fig. 3D, lanes 1-10) . Thus, similar to the observations for HIV-1 reverse transcriptase, DNA 3' end-directed cleavages and RNA 5' end-directed cleavages occurred at different locations within a given pair of matched hybrid substrates.
Together, these data showed that DNA 3' end-directed cleavages are not positioned strictly by distance, and that the M-MuLV and HIV-1 reverse transcriptases can recognize the same sites by the DNA 3' end-directed or RNA 5' enddirected types of RNase H cleavage, depending upon the substrate structure and sequence. In a matched hybrid, there is a clear tendency for more distal sites to be recognized by DNA 3' enddirected cleavages and more proximal sites to be preferred by RNA 5' end-directed cleavages.
Nature of the recessed end responsible for RNA 5' versus DNA 3' end-directed cleavages. Since matched substrates containing RNA 5' or DNA 3' ends at the same positions demonstrated distinct differences in which RNase H cleavage sites are recognized, we evaluated how the structure of a recessed end might promote an RNA 5' end-directed or DNA 3' end-directed type of cleavage. To distinguish the two types of enddirected RNase H cleavages, substrates containing the hybrid sequence of Pair 9 were used for RNA 5' end-directed cleavages at site H for HIV-1 RNase H or H' for M-MuLV RNase H, and for DNA 3' end-directed cleavage at site I for both enzymes ( Fig. 2E and 3D ).
For these experiments, we employed hybrid substrates with an RNA 5' overhang (DNA 3' end-recessed), with a blunt end, and with a recessed RNA 5' end. A hybrid substrate with an RNA 5' overhang was used in the experiments described above ( . Consequently, only data using the blunt end substrate containing Md9 is shown in Fig. 4 . These data indicated that blunt ends promoted DNA 3' end-directed cleavages and that a recessed RNA 5' end was required to direct cleavage at site H.
The cleavage pattern of HIV-1 reverse transcriptase was analyzed using hybrid substrates containing a blunt end or recessed RNA 5' ends of 1, 2, 3, 8, 11, or 38 bases. When the RNA 5' end was recessed by 1 base, equal amounts of cleavage occurred at sites I and H (Fig. 4B , lane 3 and graph). As the RNA 5' end was progressively recessed, cleavage at site H increased and cleavage at site I decreased (Fig. 4B, lanes 4-8 and graph) .
The transition between RNA 5' enddirected and DNA 3' end-directed types of cleavage was also analyzed for M-MuLV reverse transcriptase using the same substrates and monitoring cleavage at sites H' and I for RNA 5' end-directed and DNA 3' end-directed cleavages, respectively (Fig. 4C) . As was observed for HIV-1 reverse transcriptase, M-MuLV reverse transcriptase cleaved at site I with the substrate containing a recessed DNA 3' end (RNA 5' overhang) and with the substrate containing a blunt end (Fig. 3D, lane 8 and Fig. 4C , lane 2, respectively). Similarly, a substrate with an RNA 5' end recessed by 1 base was also cleaved predominately at site I (Fig. 4C, lane 3 and graph) . Sites H' and I were equally cleaved in substrates containing an RNA 5' end recessed by 2 or 3 bases (Fig. 4C, lanes 4-5 and graph) . When the substrates contained RNA ends recessed by 8 bases or more, cleavages were primarily at site H' (Fig. 4C, lanes 6-8 and graph) .
In other experiments with HIV-1 and MMuLV reverse transcriptases, we compared cleavage of substrates with RNA 5' ends recessed between 1 and 6 bases to find that RNA 5' ends recessed by 1 to 3 bases had similar levels of RNA 5' end and DNA 3' end-directed cleavage, and that ends recessed by 4, 5 or 6 bases predominantly showed RNA 5' end-directed cleavages (data not shown). Also, similar results were obtained using substrates with hybrids containing Md1 ( Fig. 1A ; data not shown). Together, these observations indicate that the shift in generating DNA 3' enddirected versus RNA 5' end-directed cleavage was determined by the distance that the RNA 5' end was recessed. Substrates that appeared to allow both DNA 3' end-directed and RNA 5' enddirected types of RNase H cleavage had a 1 base RNA 5' end recession for HIV-1 reverse transcriptase, and a 2 to 3 base recession for MMuLV reverse transcriptase.
Size of the DNA 3' end-directed cleavage window. For recognition by RNA 5' end-directed cleavage, we have previously shown that, for both M-MuLV and HIV-1 reverse transcriptases, a site in an RNA/DNA hybrid must be located within a cleavage window of 13 to 19 nucleotides from the recessed RNA 5' end (31) . Using our pairs of matched hybrid substrates, we observed that DNA 3' end-directed cleavages similarly occurred at sites with preferred sequences, but were generally found further from the recessed end than RNA 5' end-directed cleavages (Figs. 2 and 3 ). Thus we wished to establish whether these two distinct types of retroviral RNase H cleavage might have unique cleavage windows.
To define the optimal distance for DNA 3' end-directed cleavages using two different sequences, RNase H assays were designed to monitor cleavage at sites F, G, H, and I in R46 hybrids, where the DNA 3' ends ranged in increments of one nucleotide from positions T6 to +13 over a total distance of 16 nucleotides (Fig.  5A) . As a second sequence, DNA 3' ends were similarly varied over a total distance of 13 nucleotides relative to site -41/-40 in R-62/-23 hybrids (position -62 to position -50; Fig. 5B ).
When HIV-1 reverse transcriptase was analyzed using hybrid substrates containing R46, it was evident that cleavage at sites F, G, H, and I depended upon the location of the DNA 3' end relative to each site (Fig. 5C, lanes 1-17) . Most cleavage at site F was observed in substrates T6 to +2 (lanes 2-6), at site G in substrates +1 to +5 (lanes 5-9), and at site H in substrates +4 to +8 (lanes [8] [9] [10] [11] [12] . Site I only showed strong cleavage in substrates +9 and +10 (lanes [13] [14] , where the DNA 3' ends were located 18 or 19 nucleotides away, respectively. When no cleavage site was present within the optimal window for cleavage, no particular cleavage sites were favored (for example, lane 15) or cleavage shifted back to a closer site (for example, lane 16, site H). Notably, for a very strong cleavage site such as F, significantly lower but detectable levels of cleavage occurred outside of the optimal window, most likely as weaker secondary cleavages (Fig.  5C, lanes 7-13) .
To determine the size of the DNA 3' enddirected cleavage window with R46 hybrids, the amount of cleavage products generated by cleavage at sites F -I in each substrate was plotted as a function of distance from the DNA 3' end (Fig. 5E ). While there was some variation in the amount of cleavage products produced, in all cases optimal cleavage fell between 15 and 20 nucleotides from the DNA 3' end. This distance was slightly narrower and slightly further from the recessed end than the RNA 5' end-directed cleavage window of 13 to 19 nucleotides determined previously for HIV-1 reverse transcriptase (31) .
Notably, the amount of products resulting from cleavage at site I were significantly less than those observed for the other sites when site I was located 15 -17 nucleotides from the recessed DNA 3' end ( Fig. 5C and E) . This likely indicated that site I is not recognized as strongly as sites F, G, and H, and explains the smaller cleavage window surrounding site I.
To measure the cleavage window using an alternative site and sequence, similar analyses were carried out using the site -41/-40 in a series of hybrids containing R-63/-23 (Fig. 5B) . Site -41/-40 is an exceptionally strong and relatively isolated cleavage site, as the closest flanking cleavage sites are at least three bases upstream or downstream. In time course assays using hybrids containing R-63/-23 and HIV-1 reverse transcriptase, optimal cleavage at site -41/-40 occurred in substrates -60 to -55 (Fig. 5D, lanes  3-8) . When present at an optimal distance in the cleavage window, products resulting from cleavage at sites 3 to 5 bases upstream of site -41/-40 were also observed (Fig. 5D. lanes 1-4) , but very little cleavage was observed in the sequence found 3' of the -41/-40 site even when site -41/-40 cleavage decreased substantially and was not in the cleavage window (Fig. 5D, 9-13 ). The amount of product generated by cleavage at site -41/-40 in each substrate was plotted as a function of the distance from the DNA 3' end (Fig.  5F ). As described above for sites F -I in the R46 hybrids, the window for significant amounts of cleavage at site -41/-40 was located between 15 and 20 nucleotides from the DNA 3' end.
The R46 and R-63/-23 hybrid series (shown in Fig. 5A and B) were also used to determine the DNA 3' end-directed cleavage window of M-MuLV reverse transcriptase (Fig. 6) . As seen for HIV-1 RNase H, optimal cleavage of sites F, G, H, and I occurred in different substrates and depended upon the distance of the DNA 3' end from each cleavage site. Site F was cleaved in substrates T6 through T8 (Fig. 6A, lanes 2-4) , site G in substrates +1 and +2 (lanes 5, 6), site H in substrates +3, +4, and +5 (lanes 7-9), and site I in substrates +9 and +10 (lanes 13, 14) . Notably, site H', which produces a fragment one nucleotide longer than site H, was cleaved optimally in substrates +5 and +6 (lanes 9, 10). When sites F -I were not optimally positioned in the cleavage window, fewer products resulting from weaker cleavages occurred (Fig. 6A, see lanes 11 , 12, and 16). As was observed for HIV-1, for very strong cleavage sites such as F, significantly lower but detectable levels of cleavage occurred outside of the optimal window, most likely from weaker secondary cleavages (Fig. 6A, lanes 5-13) . In the R-63/-23 hybrid series, cleavage at site -41/-40 was optimal in substrates with 3' ends at positions -60, -59, and -58 (Fig. 6B, lanes 3-5) , and only weaker cleavages were seen in the other substrates (Fig. 6B, lanes 1,2, and 6-13 ). Similar to the data shown for HIV-1 reverse transcriptase, cleavage at site -41/-40 was clearly both strong and not flanked by other strong sites, and the weaker sites that were observed followed the same general trend regarding the optimal distance from the DNA 3' end for cleavage.
For both the R46 and R-63/-23 series of substrates using M-MuLV reverse transcriptase, the amount of cleavage product generated at each cleavage site, plotted as a function of the distance from the DNA 3' end, revealed that the optimal cleavage window was between 17 and 20 nucleotides from the recessed end (Fig. 6, C Effects of dNTP binding on DNA 3' enddirected cleavage by RNase H. Unlike internal or RNA 5' end-directed cleavages, DNA 3' enddirected cleavages can occur during DNA synthesis. RNase H assays are often carried out in the absence of dNTPs to simplify analyses, including the previous experiments in this study. However, given that a free DNA 3' end is a substrate for polymerase addition, and that the polymerase domain of reverse transcriptase can accommodate the RNA template strand, the 3' primer terminus of the DNA strand, and the incoming dNTPs, we asked whether the binding of cognate versus non-cognate dNTPs might affect the positioning of DNA 3' end-directed cleavages.
To assess whether nucleotide binding affects DNA 3' end-directed RNase H cleavage by M-MuLV or HIV-1 reverse transcriptase, we employed the strong and relatively isolated cleavage site -41/-40 in R-63/-23 hybrids (Fig.  1B) . The hybrids used for this analysis contained DNA primers that positioned site -41/-40 over a distance of 15 to 20 nucleotides from a DNA 3' end and that were terminated with a ddNTP to prevent primer extension (Fig. 7A) . When RNase H assays were carried out comparing hybrids with primers that had either a 3' hydroxyl terminus to hybrids with primers containing a dideoxy 3' end, cleavage products generated by HIV-1 or MMuLV reverse transcriptase were identical in all cases (data not shown). This indicated that primers with a dideoxy 3' terminus did not affect DNA 3' end-directed cleavage for either enzyme.
The R-63/-23 hybrid series containing 3' ddNTP substitutions was used in RNase H assays in the absence of dNTPs, or in the presence of either a non-cognate dNTP or the next cognate dNTP to test the effects of dNTP binding on DNA 3' end-directed RNase H cleavages. When HIV-1 reverse transcriptase was added to reactions containing 200 µM of a non-cognate dNTP, cleavage at site -41/-40 was unaffected and identical to that observed in the absence of a dNTP for all primers (compare Fig. 7B, lanes 3, 7, 11 (Fig. 7B, lanes 3, 4) . Similarly for substrate 16, the cognate dNTP decreased cleavage at site -41/-40 and significantly increased cleavage at a site present 18 nucleotides from the DNA 3' end (Fig.  7B, lanes 7, 8) . When site -41/-40 was positioned 19 nucleotides from the recessed end, the presence of the cognate dNTP slightly increased cleavages at sites found 17 and 18 nucleotides from the DNA 3' primer terminus, while decreasing cleavages at sites 16 and 15 nucleotides from the primer terminus, but did not seem to reduce cleavage of site -41/-40 significantly (Fig. 7B, lanes 19, 20) . Similarly, when site -41/-40 was positioned 20 nucleotides from the DNA 3' end, cleavage at site -41/-40 appeared unchanged but an increase in the 17 and 18 nt cleavage products and a decrease in the 16 nt cleavage product were observed (Fig.  7B, lanes 23, 24) . When compared to substrates 17 and 18, cleavage of site -41/-40 in substrates 19 and 20 is less, which correlates with the position of this site in the cleavage window as shown in the -59 and -60 substrates in Fig. 5D , lanes 4 and 3, respectively.
Thus with DNA primer 3' ends located 15, 16, 19 or 20 nucleotides away, the extent of cleavage at the -41/-40 site decreased and the extent of cleavage at positions that were 17 or 18 nucleotides from the DNA 3' end increased. Substrates containing primers 17 and 18, which already had DNA 3' ends directing cleavage at these positions, were unaffected.
In other experiments, 50 µM or 1000 µM of cognate and non-cognate deoxynucleotides had similar effects on RNase H cleavage by HIV-1 reverse transcriptase (data not shown).
The effects of cognate versus non-cognate deoxynucleotides on the RNase H activity of MMuLV reverse transcriptase were also tested using these substrates. Unlike the observations presented above for HIV-1 reverse transcriptase, no differences in DNA 3' end-directed cleavages were observed for M-MuLV reverse transcriptase in reactions containing 50 µM, 200µM, or 1000 µM of cognate versus non-cognate dNTPs (data not shown).
DISCUSSION
In this study, we tested whether DNA 3' end-directed cleavages by the RNase H activity of reverse transcriptase are strictly dictated by the interaction of the DNA primer terminus engaged in the active site of the polymerase domain of reverse transcriptase, or if DNA 3' end-directed cleavages are determined by sequence preferences within a cleavage window. Our results clearly demonstrate that DNA 3' end-directed cleavages have sequence preferences that are identical to those described for internal and RNA 5' enddirected cleavages, and that preferred sequences must fall within an acceptable distance or cleavage window from the DNA 3' end to be cleaved. Thus, the tight association of the polymerase domain with a potential 3' primer terminus does not restrict cleavage to a fixed distance from the recessed 3' end. If the DNA 3' end-directed cleavage window should happen to lack preferred sequences, then little or no DNA 3' end-directed cleavage occurs, despite the positioning afforded by the DNA 3' end on a hybrid substrate.
Previous studies with the HIV-1 and MMuLV reverse transcriptases have shown that the internal and RNA 5' end-directed RNase H cleavage sites are flanked by preferred nucleotides at specific positions, and that the preferences surrounding a site are different for the human and murine enzymes (reviewed in (8,16) ). If the scissile phosphate is defined as falling between the -1 and +1 nucleotides of an internal cleavage site, then the HIV-1 enzyme has nucleotide preferences at positions -14 (A/g), -12 (A/g/u), -7 (G/C), -4 (C/g/u), -2 (C/G), and +1 (A/U), and the MMuLV enzyme has preferences at positions -11 (A), -6 (C/G/u), -2 (C/G), and +1 (A/U) (22) . Sequence preferences for RNA 5' end-directed cleavage are essentially the same as for internal cleavage at the -4, -2 and +1 positions for HIV-1 and at the -2 and +1 positions for M-MuLV (31) . In an extension of our earlier studies with the HIV-1 and M-MuLV reverse transcriptases, we now show that the DNA 3' end-directed type of cleavage recognizes the same sites as RNA 5' enddirected cleavage. Thus, both end-directed types of RNase H cleavage by HIV-1 reverse transcriptase have nucleotide preferences at positions -4 (not A), -2 (C/G) and +1 (A/U), and by M-MuLV reverse transcriptase at positions -2 (C/G) and +1 (A/U). It is likely that the observed sequence preferences reflect features of the substrate structure that interact well with reverse transcriptase and thereby facilitate RNase H cleavage (16) .
In a number of earlier studies characterizing DNA 3' end-directed cleavages by the human or murine reverse transcriptase, sequence was not examined as a determinant of cleavage and the precise locations of the sites were not mapped. However, in reports where the sites of DNA 3' end-directed cleavages were precisely determined, the nucleotides found at positions -4, -2, and +1 for HIV-1 reverse transcriptase or at positions -2 and +1 for M-MuLV reverse transcriptase agree well with the nucleotide preferences that we have identified (23, 27, 29, 32, (36) (37) (38) . Notably, a few of these sites do have a non-preferred nucleotide at a single position and still allow some cleavage, but we have found that changes at one or even two positions are typically insufficient to completely prohibit DNA 3' end-directed cleavage and instead reduce cleavage from the optimal level (Schultz, Zhang, and Champoux, manuscript in preparation). These data argue that sequence is an important determinant for both types of enddirected RNase H cleavage by the retroviral enzymes, and that an eligible site, as defined by the nucleotide preferences identified for internal cleavage, are also recognized in the DNA 3' enddirected or RNA 5' end-directed modes of RNase H cleavage providing the site is positioned appropriately in a hybrid (see below).
Using matched hybrids, we found that DNA 3' end-directed cleavages consistently occur further from the recessed terminus than RNA 5' end-directed cleavages. For HIV-1 or M-MuLV reverse transcriptase, DNA 3' end-directed RNase H cleavages are located 15 to 20 nucleotides or 17 to 20 nucleotides away from the recessed end, respectively, whereas for both enzymes, optimal RNA 5' end-directed cleavages fall as close as 13 nucleotides from the recessed end (31) . Within the DNA 3' end-directed cleavage window, a site is cleaved distinctly better by M-MuLV reverse transcriptase when located 18 or 19 nucleotides from the DNA 3' end, and by HIV-1 reverse transcriptase when located at all distances but 17 nucleotides from the DNA 3' end. By contrast, no significant distance preferences were observed within the window for sites in the RNA 5' enddirected cleavage mode (31) .
In a noteworthy study examining the substrate requirements of secondary cleavage by HIV-1 reverse transcriptase, hybrid substrates containing primarily one RNA sequence were used to examine both DNA 3' end-directed and RNA 5' end-directed cleavages (38) .
While these substrates were not designed to compare enddirected cleavages on matched hybrid sequences, the observed primary cleavages were at 18 or 19 nucleotides from the recessed DNA 3' end (or a blunt end) and at 15 nucleotides from the recessed RNA 5' end, which is agreement with our data.
The binding interactions between reverse transcriptase and its substrate determine which types of RNase H cleavage are possible (23, 24) . Reverse transcriptase primarily interacts with a substrate near the RNase H and polymerase active sites (11) (12) (13) , and binds RNA/DNA hybrids more tightly than duplexes of DNA or RNA (24, (39) (40) (41) . There are several additional contacts predicted between reverse transcriptase and RNA/DNA hybrids, including 11 interactions with RNA 2' hydroxyls (13) , and these contacts involve as few as 5 nucleotides of RNA/DNA hybrid interacting with the polymerase domain near the active site (42) . When presented with a hybrid substrate, reverse transcriptase preferentially binds to a recessed DNA 3' or RNA 5' end (23) (24) (25) (26) , and this affinity favors end-directed RNase H cleavages over internal RNase H cleavages (26) . Rather than dissociating from a substrate to assume different binding interactions, recent experiments using single-molecule techniques have revealed that HIV-1 reverse transcriptase can both flip orientations and slide between the termini on long DNA/DNA and RNA/DNA substrates (43, 44) . Since the data in our biochemical assays is generated from a population of molecules, the importance of determinants such as sequence and distance from a recessed nucleic acid end reflect preferences in that population rather than absolute requirements in directing RNase H cleavages.
Several observations suggest that the contacts between the polymerase active site and the hybrid substrate coordinate the different types of RNase H cleavage. While both the polymerase and RNase H domains interact with substrate, most protein-nucleic acid contacts are proximal to the polymerase active site (12, 13) . Also, the distance between the polymerase and RNase H active sites is 17 to 18 nucleotides on the substrate as measured in co-crystal structures or enzymatic assays (12, 13, 15, 27, 32, 37) , and the window for DNA 3' end-directed cleavage begins at least 15 nucleotides from the recessed end. These considerations suggest that the preferred positions and nucleotides shared by all three types of cleavage (+1, -2, -4 for HIV-1, and +1 and -2 for M-MuLV) are recognized near the scissile phosphate in the active site of the RNase H domain, and that the sequence preferences at the more distal positions observed only for internal cleavage (-6, -11 for M-MuLV and -7, -12, -14 for HIV-1) and the recognition of a recessed end itself are related to substrate interactions near the active site of the polymerase domain (13, 22) .
It is interesting to consider why the cleavage windows for DNA 3' end-directed versus RNA 5' end-directed cleavages are different. There are multiple interactions between residues near the polymerase active site in the fingers and thumb subdomain of HIV-1 reverse transcriptase and a substrate with a recessed DNA 3' primer terminus (12) . Since the cleavage window for DNA 3' end-directed cleavages is narrower and further from the recessed terminus, perhaps the numerous contacts with a recessed DNA 3' end on a longer RNA strand allow the substrate to fit more securely in the active site of the polymerase domain. These interactions might reduce the flexibility of the RNase H domain, restrict access of the RNase H domain to the RNA strand, and/or place the RNase H active site at a further distance from the polymerase domain. Conversely, the closer but also broader window observed for RNA 5' end-directed cleavages may reflect that although there are multiple contacts between the recessed end and the polymerase active site that account for the higher level of RNA 5' end-directed as compared to internal cleavage, these interactions may allow more lateral movement of the substrate in the binding cleft. Some possible features of a substrate with a recessed RNA 5' end that might relax positioning in the polymerase active site are the absence of an RNA template strand that continues out of the active site, the presence of a long DNA 3' overhang, or the RNA 5' end itself. For example, perhaps the RNA 5' end acts as a "notch" that catches some region near to the polymerase active site and consequently enhances cleavage by the RNase H domain.
Based on the co-crystal structure of HIV-1 reverse transcriptase with a DNA duplex (12) , there are multiple residues (Trp-24, Pro-25, Phe-61, Ile-63, Leu-74, Asp-76, and Gly-152) that contact the template strand downstream of the primer 3' terminus and any of these residues might be candidates that facilitate RNA 5' end recognition. Notably, substitutions at Phe-61 in HIV-1 reverse transcriptase interfere with RNA 5' end-directed cleavages as well as with strand displacement synthesis (45) (46) (47) .
However, substitutions at Try-64 in M-MuLV reverse transcriptase (equivalent to Trp-24 in HIV-1) do not affect any type of RNase H cleavage but do interfere with strand displacement synthesis (48) . Unfortunately, the co-crystal structures of HIV-1 and M-MuLV reverse transcriptases to date only reveal one orientation of enzyme-substrate binding, in which the polymerase domain is bound to the 3' end of a DNA primer (11) (12) (13) (14) , and thus structures that reveal the interactions between reverse transcriptase and an RNA 5' end remain to be determined.
An interesting and related issue is how reverse transcriptase transitions between the two types of end-directed cleavage. In this work we asked if the cleavages directed by a recessed DNA 3' or RNA 5' end are mutually exclusive or if a substrate could equally favor both types of enddirected cleavage. For the HIV-1 enzyme, DNA 3' and RNA 5' end-directed RNase H cleavages appeared to occur at approximately equal levels on hybrids containing an RNA 5' end recessed by 1 base whereas for M-MuLV equal cleavage occurred with ends recessed by 2-3 bases. This intermediate cleavage pattern indicates that the positioning of reverse transcriptase to carry out RNA 5' versus DNA 3' end-directed cleavages is dynamic, and that a slightly recessed RNA 5' end in a substrate can allow positioning within the polymerase domain to permit either mode of cleavage. Since the structural basis for the binding of a recessed RNA 5' end remains unknown, precisely how this positioning shift might occur within the polymerase domain is unclear. Again, insights will come from co-crystal structures that describe the interactions between reverse transcriptase and a recessed RNA 5' end in a hybrid substrate
Our RNase H cleavage assays showed that the presence of cognate dNTP had subtle effects on DNA 3' end-directed RNase H cleavages for HIV-1 reverse transcriptase. The binding of primer-template by reverse transcriptase causes a conformational change in the position of the thumb subdomain, and when dNTP is bound to form the ternary complex, a second conformational change clamps the thumb subdomain more tightly to the substrate and moves the fingers subdomain closer to the active site of reverse transcriptase (12) . Our data suggest that the formation of the ternary complex alters the relationship between the RNase H and DNA polymerase active sites in the HIV-1 reverse transcriptase such that the binding of cognate dNTP changes the positioning of RNase H cleavages to favor cleavage at 17 or 18 nucleotides from the primer 3' end over cleavages either closer or further from this distance. Consistent with our results, a recent study has shown that a DNA primer terminated with ddTTP in the absence of a cognate dNTP was cleaved between the 19 th and 20 th nucleotides from the 3' end, and in the presence of the next cognate dNTP, cleavage was shifted back to between the 18 th and 19 th nucleotides from the 3' end (49) . The preference for cleavages at 17 to 18 nucleotides from the DNA 3' end in the ternary complex is consistent with co-crystal structures of HIV-1 reverse transcriptase showing a distance of 17 to 18 nucleotides between the polymerase and RNase H active sites (10, 11, 15) . Curiously, the formation of the ternary complex with M-MuLV reverse transcriptase does not affect the positioning of DNA 3' end-directed RNase H cleavages and is an interesting difference between the two enzymes. There are 32 additional amino acids found between the connection domain and the RNase H domain of M-MuLV reverse transcriptase as compared to HIV-1 that are predicted to make the murine RNase H domain more flexible (14) . In addition, the M-MuLV reverse transcriptase has 11 amino acids that form the C-helix and loop which are absent in the HIV-1 enzyme (14, 50) . It is possible that either of these features of the M-MuLV reverse transcriptase minimizes any structural consequences of forming the ternary complex on DNA 3' end-directed RNase H cleavages.
Because RNase H is essential for viral replication (3) (4) (5) (6) , this activity remains a promising target in developing successful drug therapies for HIV-1. Reverse transcription most likely requires all three types of RNase H cleavage, although the relative contributions by internal, DNA 3' enddirected, and RNA 5' end-directed cleavages remain unknown (8, 16, 51) . At least four different categories of RNase H inhibitors might be considered possible. First are inhibitors that block substrate binding in the active site of the retroviral RNase H. Second are inhibitors that interfere with overall substrate binding such that RNase H cleavages are increased, decreased, or changed in a manner deleterious to reverse transcription. Third are inhibitors that chelate the metal ions required for RNase H activity. And fourth are compounds that target the DNA polymerase activity of reverse transcriptase but also influence RNase H activity.
RNase H inhibitors representing several of these categories have been identified and show antiviral activity, but most display limited cellular uptake and/or high cell toxicity (reviewed in (9, 52) ), and none have been examined in clinical trials.
While the active sites of the human RNase H1 and HIV-1 RNase H are highly conserved, a comparison of co-crystal structures of these enzymes has revealed intriguing structural differences that may influence substrate binding or enzyme activity in a manner that would allow for the design of inhibitors specifically targeting the viral RNase H (53) . Notably, a recently identified hydroxylated tropolone displays a 30-fold selectivity for the HIV-1 RNase H over the human enzyme (54) .
To screen for drugs that preferentially inhibit HIV-1 RNase H, assays that discriminate between internal, RNA 5' enddirected, and DNA 3' end-directed cleavages should be considered. For example, an inhibitor that specifically blocks the end-directed modes of retroviral RNase H cleavage but does not alter internal RNase H cleavages might selectively interfere with the retroviral RNase H and reverse transcription without significantly impacting the endogenous human RNase H1 activity. A. Matched hybrid substrates were created by placing the recessed end of the shorter RNA or DNA strand at the same location (position 1, 4, 7, or 9 as labeled in Fig. 1A ) on the longer DNA or RNA strand, respectively (Recessed end position; indicated by a dashed line). RNA strands are gray, DNA strands are black, and 3' ends are indicated by arrowheads. For substrates containing a recessed RNA 5' end (top illustration), the shorter RNAs Md1, Md4, Md7, and Md9 were annealed to D46, a longer complementary DNA strand that is equivalent to R46. For substrate containing a recessed DNA 3' end (bottom illustration), the shorter DNAs Cd1, Cd4, Cd7, and Cd9 were annealed to R46. The 5' ends of all RNAs were end-labeled (indicated by an asterisk). B. Pair 1 RNase H assay using matched hybrid substrates Md1/D46 (RNA 5' end; lanes 1-5) and Cd1/R46 (DNA 3' end; lanes 6-10). Substrates were either untreated (labeled as C for control) or samples were removed at 0.25, 1, 4 or 16 min after incubation with HIV-1 reverse transcriptase, and analyzed in denaturing 20% polyacrylamide gels. Results were visualized using a Phosphorimager. Products generated by cleavage at the same site in each pair are connected by dashed lines and labeled according to the cleavage sites shown in Fig. 1A . Distance (Dist.) is the number of nucleotides between the recessed end, counted as nucleotide 1, and the 5' nucleotide bordering the cleavage site. Identical assays using the other matched pairs of hybrid substrates are shown in Panels C-E. C. Pair 4 assay with Md4/D46 (lanes 1-5) and Cd4/R46 (lanes 6-10) . D. Pair 7 assay with Md7/D46 (lanes 1-5) and Cd7/R46 (lanes 6-10). E. Pair 9 assay with Md9/D46 (lanes 1-5) and Cd9/R46 (lanes 6-10). HIV-1 reverse transcriptase was incubated with hybrid substrates containing R46 (C) or R-63/-23 (D) and 1 min samples from each reaction were analyzed as described in Fig. 2 . In C, the positions of R46 and products resulting from cleavage at sites F, G, H, and I are indicated (lanes 1-17) . In D, the positions of R-63/-23 and only the products resulting from cleavage at site -41/-40 are indicated (lanes 1-14) . E & F. The amount of product generated by cleavage (% of total) at the sites F, G, H, and I or at site -41/-40 is plotted as a function of distance of the site in nucleotides from the DNA 3' end of each substrate, with the distance measured between the 3' end (nucleotide 1) and the 5' nucleotide bordering the cleavage site. For the graph in E, data from six independent experiments were averaged. For the graph in F, data from a single representative experiment was used. ///)/+7+))7/)))/)++++)++7/7)//777//+))/+7)/+77 R46 ///)/+7+/++7)7)/)/7)+/)/++)7)/)7))))7))))/)7777) 7 
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